G. Catalano

发表

The Management Of Double Neoplasms: A Case Of A Patient With Small Cell Lung And Gastric Cancer Successfully Treated With Chemotherapy

V. Catalano, D. Rossi, P. Giordani, 2004 .

Pain and its treatment in hospitalized patients with metastatic cancer

S. Barni, R. Labianca, G. Beretta, 2003, Supportive Care in Cancer.

Pamidronate in patients with painful bone metastases, who failed initial treatment with hormones and/or chemotherapy

S. Cascinu, P. Alessandroni, V. Casadei, 2005, Supportive Care in Cancer.

Gastrointestinal Cancer Refractory to Chemotherapy: A Role for Octreotide?

V. Catalano, S. Cascinu, P. Giordani, 2001, Chemotherapy.

Inhibition of tumor cell kinetics and serum insulin growth factor I levels by octreotide in colorectal cancer patients.

S. Cascinu, V. Saba, R. Ghiselli, 1997, Gastroenterology.

Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells.

D. Adams, Y. Tanaka, D. Bottaro, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Preoperative Chemo-Radiotherapy for Carcinoma of the Esophagus

E. Martinelli, F. Morgillo, G. Catalano, 2001, Tumori.

Recombinant human erythropoietin treatment in elderly cancer patients with cisplatin-associated anemia.

S. Cascinu, P. Alessandroni, A. Fedeli, 1995, Oncology.

Tumor markers in the diagnosis of malignant serous effusions.

S. Cascinu, A. Fedeli, G. Catalano, 1997, American journal of clinical oncology.

Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target.

F. Ciardiello, G. Catalano, F. Giuliani, 2010, Cancer treatment reviews.

Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer

V. Catalano, S. Cascinu, F. Graziano, 2001, BMC Cancer.

Chemotherapy for Advanced Pancreatic Cancer: The History is Changing

S. Cascinu, F. Graziano, G. Catalano, 1998, Tumori.

Adjuvant Systemic Therapies in Patients with Colorectal Cancer: An Audit on Clinical Practice in Italy

S. Barni, R. Labianca, G. Luporini, 2005, Tumori.

Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial.

R. Labianca, V. Catalano, G. Beretta, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunohistochemical determination of p53 protein does not predict clinical response in advanced colorectal cancer with low thymidylate synthase expression receiving a bolus 5-fluorouracil-leucovorin combination.

S. Barni, V. Catalano, D. Debernardis, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

High-dose loperamide in the treatment of 5-fluorouracil-induced diarrhea in colorectal cancer patients

D. Amadori, V. Catalano, S. Cascinu, 2000, Supportive Care in Cancer.

Resection-line involvement in gastric cancer patients undergoing curative resections: implications for clinical management.

V. Catalano, S. Cascinu, P. Giordani, 1999, Japanese journal of clinical oncology.

S‐phase fraction can predict event free survival in patients with pT2‐T3N0M0 colorectal carcinoma

S. Cascinu, F. Graziano, G. Catalano, 1998, Cancer.

Different doses of pamidronate in patients with painful osteolytic bone metastases

D. Rossi, S. Cascinu, F. Graziano, 1998, Supportive Care in Cancer.

Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial.

S. Cascinu, G. Catalano, E. Del Ferro, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Amifostine: A selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review).

S. Infusino, G. Catalano, M. Orditura, 1999, Oncology reports.

Delayed emesis induced by moderately emetogenic chemotherapy: do we need to treat all patients? The Italian Group for Antiemetic Research.

A. Favero, C. Boni, M. Tonato, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

A multicentre, double-blind, randomised trial comparing ondansetron versus ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis.

S. Iacobelli, C. Gridelli, A. Bianco, 1997, International journal of oncology.

Neo-adjuvant and adjuvant chemotherapy of gastric cancer.

F. Ciardiello, G. Catalano, G. Santabarbara, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer.

V. Catalano, S. Cascinu, F. Graziano, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo.

S. Cascinu, A. Fedeli, G. Catalano, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recombinant human erythropoietin in chemotherapy-associated anemia.

S. Cascinu, R. Cellerino, G. Catalano, 1995, Cancer treatment reviews.

Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients.

G. Catalano, G. Catalano, M. Orditura, 2000, Chest.

Prolonged corrected QT dispersion.

B. Sarubbi, L. Santangelo, G. Catalano, 1997, Oncology reports.

Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients

S. Barni, R. Labianca, G. Luporini, 1997, Supportive Care in Cancer.

Thrombocytosis and Gemcitabine

V. Catalano, D. Rossi, P. Giordani, 2001 .

Chemotherapy for advanced pancreatic cancer: it may no longer be ignored.

S. Cascinu, F. Graziano, G. Catalano, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of paclitaxel in pretreated advanced gastric cancer

S. Cascinu, F. Graziano, P. Giordani, 1998, Anti-cancer drugs.

Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.

H. McLeod, F. Caponigro, A. Avallone, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase II study of weekly docetaxel and capecitabine in patients with metastatic gastric cancer (GC)

F. Ciardiello, G. Catalano, M. Orditura, 2005 .

Adjuvant chemotherapy of gastric cancer: which regimens?

F. Ciardiello, G. Catalano, M. Orditura, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

A Phase II Study of Single-Agent Oral Vinorelbine in Patients with Pretreated Advanced Non–Small-Cell Lung Cancer riginal

V. Catalano, D. Rossi, P. Giordani, 2007 .

Control of chemotherapy-induced diarrhea with octreotide. A randomized trial with placebo in patients receiving cisplatin.

S. Cascinu, S. Fedeli, A. Fedeli, 1994, Oncology.

Serum interleukin‐10 levels in patients with advanced gastrointestinal malignancies

G. Catalano, S. Infusino, G. Catalano, 1999, Cancer.

Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancer.

G. Catalano, S. Infusino, G. Catalano, 1998, Oncology reports.

Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study.

S. Cascinu, S. Fedeli, A. Fedeli, 1993, British Journal of Cancer.

Durable Response To Capecitabine (Xeloda; Roche) In An Elderly Patient With Liver And Bone Metastases Of Breast Cancer

V. Catalano, D. Rossi, P. Giordani, 2005 .

Serum concentrations of proinflammatory cytokines in advanced non small cell lung cancer patients.

S. Infusino, G. Catalano, M. Orditura, 1998, Journal of experimental & clinical cancer research : CR.

Efficacy and safety profile of amifostine in the preoperative combined therapy of esophageal cancer patients.

G. Catalano, M. Orditura, G. Abbate, 2000, Oncology reports.

Experience with Intrapleural Natural Beta Interferon in the Treatment of Malignant Pleural Effusions

S. Cascinu, S. Fedeli, A. Fedeli, 1991, Tumori.

Breast cancer developing after therapy for Hodgkin's disease.

S. Cascinu, A. Fedeli, G. Catalano, 1993, Clinical oncology (Royal College of Radiologists (Great Britain)).

Control of Chemotherapy-Induced Diarrhea with Octreotide

S. Cascinu, S. Fedeli, A. Fedeli, 1994 .

Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial.

S. Cascinu, S. Fedeli, A. Fedeli, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of "bioelectrical impedance analysis" in the evaluation of the nutritional status of cancer patients.

G. Catalano, A. Perrelli, G. Guarino, 1993, Advances in experimental medicine and biology.

Multimodal biochemical modulation of 5-fluorouracil by leucovorin, methotrexate, and interferon alpha in patients with advanced colorectal cancer

D. Rossi, S. Cascinu, P. Alessandroni, 1996, Cancer Chemotherapy and Pharmacology.

Differences of vascular endothelial growth factor (VEGF) expression between liver and abdominal metastases from colon cancer. Implications for the treatment with VEGF inhibitors

S. Barni, V. Catalano, S. Cascinu, 2004, Clinical & Experimental Metastasis.

Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator.

E. Martinelli, G. Catalano, G. Catalano, 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Expression of epidermal growth factor receptor (EGFR) correlates with disease relapse and progression to androgen-indepedence in human prostate cancer

R. Autorino, S. Staibano, G. Tortora, 2002 .

Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer.

S. Barni, R. Labianca, G. Luporini, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation

S. Barni, V. Catalano, S. Cascinu, 2002, British Journal of Cancer.

A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy.

S. Cascinu, G. Catalano, E. D. Ferro, 1995, British Journal of Cancer.

Neoadjuvant chemotherapy with low dose of pegylated liposomal doxorubicin plus weekly paclitaxel in operable and locally advanced breast cancer

V. Catalano, D. Rossi, F. Graziano, 2008, Anti-cancer drugs.

Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: relationships with tumor recurrence and resistance to adjuvant chemotherapy.

V. Catalano, C. Rossi, S. Cascinu, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Serum Vascular Endothelial Growth Factor (VEGF) Levels Correlate with Tumor VEGF and p53 Overexpression in Endocrine Positive Primary Breast Cancer

F. Ciardiello, F. Morgillo, G. Catalano, 2008, Cancer investigation.

Weekly Docetaxel as Second-Line Therapy in Non-Small Cell Lung Cancer: A Phase II Study

V. Catalano, D. Rossi, F. Graziano, 2004, Tumori.

The Role of Levamisole in the Adjuvant Treatment of Stage III Colon Cancer Patients: A Randomized Trial of 5-Fluorouracil and Levamisole Versus 5-Fluorouracil Alone

A. Piga, V. Catalano, S. Cascinu, 2003, Cancer investigation.

Expression of p53 protein and resistance to preoperative chemotherapy in locally advanced gastric carcinoma

S. Cascinu, F. Graziano, P. Muretto, 1998, Cancer.

Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: a randomized multicenter study.

O. Nanni, E. Scarpi, D. Amadori, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?

V. Catalano, D. Rossi, B. Vincenzi, 2008, British Journal of Cancer.

Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer.

V. Catalano, C. Rossi, G. Gasparini, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Double biochemical modulation of 5-fluorouracil by methotrexate and levo-folinic acid in the treatment of advanced digestive tract malignancies.

V. Lorusso, G. Comella, G. Catalano, 1996, European journal of cancer.

Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.

R. Labianca, V. Torri, A. Piga, 2008, Journal of the National Cancer Institute.

Salvage chemotherapy in colorectal cancer patients with good performance status and young age after failure of 5-fluorouracil/leucovorin combination.

S. Cascinu, A. Fedeli, G. Catalano, 1992, Journal of chemotherapy.

Serum interleukin-10 is an independent prognostic factor in advanced solid tumors.

G. Catalano, M. Orditura, E. Lieto, 2000, Oncology reports.

Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: a phase II study.

F. Ciardiello, E. Martinelli, G. Catalano, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

S. Barni, R. Labianca, G. Luporini, 1999, British Journal of Cancer.

Cisplatin, 5-fluorouracil and interferon alpha 2b for recurrent or metastatic head and neck cancer.

S. Cascinu, A. Fedeli, G. Catalano, 1994, British Journal of Cancer.

Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil.

S. Barni, V. Catalano, D. Debernardis, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancer.

S. Barni, R. Labianca, L. Frontini, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase I study of paclitaxel and 5-fluorouracil in advanced gastric cancer.

S. Cascinu, R. Cellerino, F. Graziano, 1997, European journal of cancer.

Have enteric infections a role in 5-fluorouracil-associated diarrhea?

S. Cascinu, G. Catalano, 1995, Supportive Care in Cancer.

Vascular Endothelial Growth Factor and p53 Expressions in Liver and Abdominal Metastases from Colon Cancer

S. Barni, V. Catalano, C. Rossi, 2003, Tumor Biology.

Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer.

V. Catalano, D. Rossi, P. Giordani, 2007, Clinical breast cancer.

A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients

E. Matano, F. Ciardiello, R. Bianco, 2005, British Journal of Cancer.

Gastric Metastases from Breast Cancer: A Case Report

S. Cascinu, S. Fedeli, A. Fedeli, 1989, Tumori.

Epirubicin Followed by Cyclophosphamide, Methotrexate and 5-Fluorouracil versus Paclitaxel Followed by Epirubicin and Vinorelbine in Patients with High-Risk Operable Breast Cancer

D. Amadori, P. Sismondi, F. Boccardo, 2010, Oncology.

The clinical impact of teniposide in the treatment of elderly patients with small-cell lung cancer.

S. Cascinu, F. Graziano, G. Catalano, 1997, American journal of clinical oncology.

Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase II-III randomized trial.

A. Avallone, V. Lorusso, M. de Lena, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Gemcitabine plus epirubicin in advanced pancreatic cancer: a phase II multicenter trial.

G. Catalano, M. Orditura, G. Ianniello, 2001, Oncology Report.

Etoposide, leucovorin, 5-fluorouracil and interferon alpha-2b in elderly gastric cancer patients: a pilot study

S. Cascinu, A. Fedeli, G. Catalano, 2004, Cancer Chemotherapy and Pharmacology.

Double biochemical modulation of 5-fluorouracil by leucovorin and cyclic low dose interferon alpha 2b in advanced colorectal cancer patients.

S. Cascinu, S. Fedeli, A. Fedeli, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Inhibition of Vascular Endothelial Growth Factor by Octreotide in Colorectal Cancer Patients

V. Catalano, S. Cascinu, P. Giordani, 2001, Cancer investigation.

Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

S. Barni, R. Labianca, L. Frontini, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Oxaliplatin and raltitrexed combined with leucovorin-modulated 5-fluorouracil i.v. bolus every two weeks: a dose finding study in advanced previously treated colorectal carcinoma. Southern Italy Cooperative Oncology Group.

A. Avallone, G. Comella, G. Catalano, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

A Pilot Clinical Trial of Surgical Adjuvant Treatment with High-Dose 6S-Leucovorin/5-Fluorouracil and Radiation Therapy for High-Risk Rectal Carcinoma

S. Cascinu, V. Saba, R. Ghiselli, 1994, Tumori.

A multicenter phase II study of induction CT with FOLFOX-4 and cetuximab followed by RT and cetuximab in locally advanced esophageal cancer (LAEC).

V. Chiarion Sileni, A. Ruol, F. Ciardiello, 2009, Journal of Clinical Oncology.

Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients

A. Avallone, V. Lorusso, G. Comella, 2002, British Journal of Cancer.

A phase I-II study of gemcitabine and docetaxel in advanced pancreatic cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

V. Catalano, G. Gasparini, S. Cascinu, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

5-Fluorouracil dose intensity increase in 5-fluorouracil and leucovorin combination: results of a phase II study.

S. Cascinu, A. Fedeli, G. Catalano, 1991, Journal of chemotherapy.

A phase II study of single-agent oral vinorelbine in patients with pretreated advanced non-small-cell lung cancer.

V. Catalano, D. Rossi, P. Giordani, 2007, Clinical lung cancer.

Toxicity and therapeutic response to chemotherapy in patients aged 70 years or older with advanced cancer.

S. Cascinu, G. Catalano, E. D. Ferro, 1996, American journal of clinical oncology.

A combined analysis of the Deleted in Colon Cancer ( DCC ) and the p 53 proteins expression in gastric cancer

V. Catalano, P. Giordani, P. Muretto, 2001 .

A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer

S. Barni, R. Labianca, L. Frontini, 2001, British Journal of Cancer.

Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis.

S. Cascinu, S. Fedeli, A. Fedeli, 1994, European journal of cancer. Part B, Oral oncology.

Intensive weekly chemotherapy for advanced gastric-cancer using 5-Fluorouracil, Cisplatin, epi-Doxorubicin, 6s-leucovorin and granulocyte-colony-stimulating factor.

S. Cascinu, S. Fedeli, A. Fedeli, 1993, International journal of oncology.

Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study).

F. Ciardiello, G. Colucci, E. Maiello, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Control of chemotherapy-induced diarrhoea with octreotide in patients receiving 5-fluorouracil.

S. Cascinu, S. Fedeli, A. Fedeli, 1992, European journal of cancer.

A Pilot Clinical Trial of Postoperative Adjuvant Intraperitoneal Cisplatin, 5-Fluorouracil, 6S-Leucovorin and Interferon Alpha 2b in Patients with Resected Gastric Cancer

S. Cascinu, G. Catalano, Gabriele Valentini, 1993, Tumori.

Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.

V. Catalano, D. Rossi, F. Graziano, 2008, Clinical lung cancer.

Effects of Calcium and Vitamin Supplementation on Colon Cell Proliferation in Colorectal Cancer

V. Catalano, M. Rocchi, S. Cascinu, 2000, Cancer investigation.

Induction primary CT with Folfox-4 and cetuximab followed by RT and cetuximab in locally advanced esophageal cancer (LAEC): Analysis of preliminary data from B152 Trial

F. Ciardiello, E. Martinelli, C. Pinto, 2008 .

[Primary lymphoma of the parotid: a rare location].

N. Carlomagno, G. Catalano, M. Orditura, 1994, Recenti progressi in medicina.

Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer : A low cost effective regimen

S. Barni, R. Labianca, L. Frontini, 2002, British Journal of Cancer.

5-Fluorouracil, leucovorin and interferon alpha 2b in advanced pancreatic cancer: a pilot study.

S. Cascinu, S. Fedeli, A. Fedeli, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Fixed dose rate (FDR) gemcitabine (G) and capecitabine (C) in patients with metastatic biliary tract cancer (BTC): Final results of phase II trial.

E. Vasile, V. Catalano, B. Vincenzi, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of 13-cis retinoic acid plus interferon-alpha in advanced squamous cell carcinoma of head and neck, refractory to chemotherapy.

S. Cascinu, F. Graziano, G. Catalano, 1996, Annals of Oncology.

Is an Antiemetic Prophylactic Treatment Needed for Patients Submitted to Consecutive Days of 5-fluorouracil? An Observational Study

A. Favero, M. Maltoni, D. Amadori, 2001, Tumori.

Intensive Weekly Chemotherapy for Elderly Gastric Cancer Patients, Using 5-Fluorouracil, Cisplatin, Epi-Doxorubicin, 6S-Leucovorin and Glutathione with the Support of G-CSF

S. Cascinu, G. Catalano, 1995, Tumori.

A Pilot Clinical Trial of Postoperative Intensive Weekly Chemotherapy Using Cisplatin, Epi-Doxorubicin, 5-Fluorouracil, 6S-Leucovorin, Glutathione and Filgrastim in Patients with Resected Gastric Cancer

S. Cascinu, F. Graziano, E. Menichetti, 1998, Tumori.

Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

S. Barni, R. Labianca, G. Luporini, 1998, British Journal of Cancer.

Gemcitabine (GEM) and 5-fluorouracil (5 FU) in advanced pancreatic cancer: A GISCAD phase II study

R. Labianca, L. Frontini, S. Cascinu, 1997 .

A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

S. Barni, R. Labianca, L. Frontini, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

M. Pirovano, S. Barni, R. Labianca, 1999, British Journal of Cancer.

S‐phase fraction and tumor aneuploidy in colorectal carcinoma of young patients

S. Cascinu, G. Catalano, M. Ligi, 1996, Cancer.